Pacifica Partners Inc. Amgen Inc Transaction History

Pacifica Partners Inc.

$223 Million
Q1 2024

A detailed history of Pacifica Partners Inc. transactions in Amgen Inc stock. As of the latest transaction made, Pacifica Partners Inc. holds 1,112 shares of AMGN stock, worth $345,698. This represents 0.14% of its overall portfolio holdings.

Number of Shares

1,112

Previous 1,123 0.98%

Holding current value

$345,698

Previous $323,000 2.17%

% of portfolio

0.14%

Previous 0.16%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $2,957 - $3,570	-11 Reduced 0.98%	1,112 $316,000
Q4 2023 Jan 05, 2024	BUY	$255.7 - $288.46 $46,026 - $51,922	180 Added 19.09%	1,123 $323,000
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $65,595 - $81,438	300 Added 46.66%	943 $253,000
Q2 2023 Jul 14, 2023	SELL	$214.27 - $253.37 $642 - $760	-3 Reduced 0.46%	643 $142,000
Q1 2023 Apr 11, 2023	SELL	$225.79 - $275.2 $3,386 - $4,128	-15 Reduced 2.27%	646 $156,000

Q4 2022 Jan 11, 2023	BUY	$229.03 - $291.01 $4,122 - $5,238	18 Added 2.8%	661 $174,000
Q3 2022 Oct 14, 2022	BUY	$224.46 - $253.15 $11,223 - $12,657	50 Added 8.43%	643 $150,000
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $1,845 - $2,053	-8 Reduced 1.33%	593 $147,000
Q1 2022 Apr 12, 2022	BUY	$219.27 - $242.57 $8,770 - $9,702	40 Added 7.13%	601 $137,000
Q4 2021 Jan 13, 2022	SELL	$198.88 - $227.6 $2,983 - $3,414	-15 Reduced 2.6%	561 $117,000
Q2 2021 Jul 14, 2021	BUY	$233.58 - $259.14 $4,438 - $4,923	19 Added 3.41%	576 $141,000
Q1 2021 Apr 08, 2021	BUY	$221.91 - $258.6 $7,323 - $8,533	33 Added 6.3%	557 $140,000
Q4 2020 Jan 13, 2021	SELL	$216.38 - $257.67 $16,228 - $19,325	-75 Reduced 12.52%	524 $117,000
Q2 2020 Jul 15, 2020	SELL	$197.81 - $242.74 $2,571 - $3,155	-13 Reduced 2.12%	599 $154,000
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $115,796 - $148,838	612 New	612 $148,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacifica Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacifica Partners Inc. with notifications on news.

Account

Pacifica Partners Inc. Amgen Inc Transaction History